Interferon-γ is required for lupus nephritis in mice treated with the hydrocarbon oil pristane

被引:95
作者
Richards, HB
Satoh, M
Jennette, JC
Croker, BP
Yoshida, H
Reeves, WH
机构
[1] Univ Florida, Div Clin Immunol & Rheumatol, Dept Med, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Pathol, Gainesville, FL 32610 USA
[3] Univ N Carolina, Dept Pathol, Chapel Hill, NC USA
关键词
glomerulonephritis; antinuclear antibodies; pristane; immune complex disease; systemic lupus erythematosus;
D O I
10.1046/j.1523-1755.2001.00045.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Although the precise mechanisms leading to lupus nephritis remain obscure, both T(H)1 and T(H)2 cytokines have been implicated. The present study examined the roles of interleukin (IL)-4 and interferon-gamma (IFN-gamma) in a novel inducible form of lupus that develops in non-autoimmune mice treated with the hydrocarbon oil pristane. Methods. BALB/c IL-4 or IFN-gamma deficient mice (IL-4 -/-, IFN gamma -/-) and wild type controls (+/+) received either pristane or phosphate-buffered saline (PBS) IP. Serial sera were analyzed for anti-DNA/chromatin, anti-RNP/Sm, and total immunoglobulin levels. Proteinuria was measured and kidneys were examined by direct immunofluorescence and light microscopy. Results. Renal disease did not develop in pristane-treated IFN-gamma -/- mice, as assessed by the absence of capillary immune deposits, glomerular pathology and proteinuria whereas IL-4 -/- mice developed renal disease similar to +/+ mice. Production of IgG anti-single stranded DNA and anti-chromatin antibodies was abrogated in IFN-gamma -/- mice. In contrast, these autoantibodies were produced at similar or higher frequencies and levels by IL-4 -/- versus wild-type mice. The frequency of anti-nRNP/Sm was markedly reduced in IFN-gamma -/- mice. IL-4 deficiency had little effect on the production of anti-DNA/chromatin and anti-nRNP/Sm. Conclusions. IFN-gamma is essential for the induction of nephritis and anti-DNA/chromatin following pristane exposure in BALB/c mice, suggesting that genetic or environmental factors influencing T(H)1-T(H)2 balance could be an important determinant of renal disease in lupus.
引用
收藏
页码:2173 / 2180
页数:8
相关论文
共 48 条
  • [1] Akahoshi M, 1999, ARTHRITIS RHEUM, V42, P1644, DOI 10.1002/1529-0131(199908)42:8<1644::AID-ANR12>3.0.CO
  • [2] 2-L
  • [3] SPONTANEOUS MURINE LUPUS-LIKE SYNDROMES - CLINICAL AND IMMUNOPATHOLOGICAL MANIFESTATIONS IN SEVERAL STRAINS
    ANDREWS, BS
    EISENBERG, RA
    THEOFILOPOULOS, AN
    IZUI, S
    WILSON, CB
    MCCONAHEY, PJ
    MURPHY, ED
    ROTHS, JB
    DIXON, FJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (05) : 1198 - 1215
  • [4] RENAL INVOLVEMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) - STUDY OF 56 PATIENTS EMPHASIZING HISTOLOGIC CLASSIFICATION
    APPEL, GB
    SILVA, FG
    PIRANI, CL
    MELTZER, JI
    ESTES, D
    [J]. MEDICINE, 1978, 57 (05) : 371 - 410
  • [5] Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice
    Balomenos, D
    Rumold, R
    Theofilopoulos, AN
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) : 364 - 371
  • [6] BURSTEIN HJ, 1991, J IMMUNOL, V147, P2950
  • [7] Increased interferon-gamma (IFN-γ), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)
    Csiszár, A
    Nagy, G
    Gergely, P
    Pozsonyi, T
    Pócsik, É
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 122 (03) : 464 - 470
  • [8] MULTIPLE DEFECTS OF IMMUNE CELL-FUNCTION IN MICE WITH DISRUPTED INTERFERON-GAMMA GENES
    DALTON, DK
    PITTSMEEK, S
    KESHAV, S
    FIGARI, IS
    BRADLEY, A
    STEWART, TA
    [J]. SCIENCE, 1993, 259 (5102) : 1739 - 1742
  • [9] TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON-ALFA - A MULTICENTER RANDOMIZED, CONTROLLED TRIAL
    DAVIS, GL
    BALART, LA
    SCHIFF, ER
    LINDSAY, K
    BODENHEIMER, HC
    PERRILLO, RP
    CAREY, W
    JACOBSON, IM
    PAYNE, J
    DIENSTAG, JL
    VANTHIEL, DH
    TAMBURRO, C
    LEFKOWITCH, J
    ALBRECHT, J
    MESCHIEVITZ, C
    ORTEGO, TJ
    GIBAS, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) : 1501 - 1506
  • [10] DEWIT D, 1993, J IMMUNOL, V150, P361